Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesLoans and Notes ReceivablesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares Outstanding
Ratios

Zhengye Biotechnology Holding (ZYBT) Shares Outstanding (2023 - 2025)

Zhengye Biotechnology Holding has reported Shares Outstanding over the past 3 years, most recently at $5.6 million for Q4 2025.

  • Quarterly Shares Outstanding rose 614.93% to $5.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.6 million through Dec 2025, up 614.93% year-over-year, with the annual reading at $5.6 million for FY2025, 605.83% up from the prior year.
  • Shares Outstanding was $5.6 million for Q4 2025 at Zhengye Biotechnology Holding, up from $5.6 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $5.6 million in Q4 2025 and troughed at $786988.2 in Q4 2023.
  • The 3-year median for Shares Outstanding is $5.6 million (2024), against an average of $4.0 million.
  • Year-over-year, Shares Outstanding crashed 50.25% in 2024 and then skyrocketed 614.93% in 2025.
  • A 3-year view of Shares Outstanding shows it stood at $1.6 million in 2023, then crashed by 50.25% to $788848.6 in 2024, then skyrocketed by 614.93% to $5.6 million in 2025.
  • Per Business Quant, the three most recent readings for ZYBT's Shares Outstanding are $5.6 million (Q4 2025), $788848.6 (Q4 2024), and $1.6 million (Q4 2023).